We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Okyo Pharma Limited | LSE:OKYO | London | Ordinary Share | GG00BD3FV870 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 91.00 | 1.20 | 1.60 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOKYO
RNS Number : 3356Z
OKYO Pharma Limited
15 May 2023
OKYO Pharma Limited
("OKYO" or "Company")
Change of Record Time and Last Day of Dealings
London, May 15, 2023 - OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease ("DED") to address the significant unmet need in this multi-billion-dollar market, previously announced a date of 12 May 2023 on which the cancellation of its ordinary shares of no par value each ("Ordinary Shares") from listing on the standard segment of the FCA's Official List and trading on the main market for listed securities of the LSE ("Main Market") ("Delisting") were to occur. The Delisting will now take place on Monday, 22 May 2023 to facilitate late transfers of certificated positions into CREST ahead of the Delisting.
As such, in keeping with the change of Delisting date, the Company today announces a revised timetable of principal events including a change to the record time and last day of dealings in the existing Ordinary Shares on the Main Market. The revised timetable is as follows:
Record Time close of business on 18 May 2023 Last day of dealings in the Existing Ordinary Shares on the Main Market 19 May 2023 --------------------------------------- Main Market Delisting 8.00 a.m. on 22 May 2023 --------------------------------------- ADR Facility Termination 8.00 a.m. on 22 May 2023 --------------------------------------- Share Capital Consolidation effective 8.00 a.m. on 22 May 2023 --------------------------------------- Date for filing of registration statement on Form F-1 which will, upon By 16 April 2023 effectiveness, give such holders of New Ordinary Shares the ability to freely resell such restricted securities --------------------------------------- Date for crediting of the New Ordinary Shares in uncertificated to DTC 22 May 2023 members' accounts --------------------------------------- Effectiveness of New Ordinary Shares Nasdaq Listing and commencement of 22 May 2023 trading in New Ordinary Shares on Nasdaq --------------------------------------- Date of dispatch of DR S statements in respect of the New Ordinary Shares in Within 10 Business Days of 22 May 2023 certificated form ---------------------------------------
The securities to which the Delisting relates are the Ordinary Shares of OKYO Pharma Limited with ISIN GG00BD3FV870. Following the Delisting, it will no longer be possible to trade the Ordinary Shares on the Main Market or any other market of the LSE.
Enquiries:
Gary S. Jacob, OKYO Pharma Limited Chief Executive Officer +44 (0)20 7495 2379 Investor Relations Paul Spencer +44 (0)20 7495 2379 Optiva Securities Limited (Broker) Robert Emmet +44 (0)20 3981 4173
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCLZLFFXELLBBE
(END) Dow Jones Newswires
May 15, 2023 02:00 ET (06:00 GMT)
1 Year Okyo Pharma Chart |
1 Month Okyo Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions